BEAM
Beam Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+9.42%
vs ±13.3% implied · ×0.71
shaded = implied · ▲▼ = realized
No thesis.
Beam Therapeutics Inc.
27.04
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $432.7M | 11.44% | +1.26% | |
| 2 | Farallon Capital ManagementFarallon | $351.3M | 9.29% | new | |
| 3 | ARK Investment ManagementARK | $351.3M | 9.29% | −15.65% | |
| 4 | BlackRockBlackRockindex-like | $308.8M | 8.17% | +6.01% | |
| 5 | State StreetState Streetindex-like | $200.0M | 5.29% | +2.24% | |
| 6 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $168.9M | 4.47% | +7.67% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $157.9M | 4.17% | +5.07% | |
| 8 | Arch VentureArch Venture | $155.8M | 4.12% | 0.00% | |
| 9 | Sumitomo Mitsui Trust HoldingsSumitomo Mitsui Trust | $118.6M | 3.14% | −9.69% | |
| 10 | Nikko Asset Management AmericasNikko Asset Management Americas | $118.5M | 3.13% | −9.69% | |
| 11 | T. Rowe Price AssociatesT. Rowe Price | $117.2M | 3.10% | +25.87% | |
| 12 | Kynam Capital ManagementKynam | $97.5M | 2.58% | −22.85% | |
| 13 | Geode Capital ManagementGeodeindex-like | $89.1M | 2.36% | +7.37% | |
| 14 | Dimensional Fund AdvisorsDimensional | $76.4M | 2.02% | +3.31% | |
| 15 | Morgan StanleyMorgan Stanley | $67.0M | 1.77% | +200.95% | |
| 16 | Contrarius Group HoldingsContrarius | $55.4M | 1.47% | +202.66% | |
| 17 | UBS Asset Management AmericasUBS Asset Management Americas | $53.3M | 1.41% | −6.16% | |
| 18 | Two Sigma InvestmentsTwo Sigma | $47.6M | 1.26% | +14.65% | |
| 19 | Casdin CapitalCasdin Capital | $46.3M | 1.23% | 0.00% | |
| 20 | Goldman Sachs GroupGoldman Sachs | $45.0M | 1.19% | +30.26% | |
| 21 | Redmile GroupRedmile | $40.0M | 1.06% | −5.93% | |
| 22 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $36.6M | 0.97% | +52.41% | |
| 23 | Deep Track CapitalDeep Track Capital | $34.3M | 0.91% | +21.84% | |
| 24 | Northern TrustNorthern Trustindex-like | $32.0M | 0.85% | +13.07% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $30.4M | 0.80% | +9.58% |
275 managers report $3.8B of Beam Therapeutics on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; FMR is largest at 11.44%.
Expected move
Inputsspot 27.23exp Nov 20ATM strike 27ATM straddle 3.87IV 75%